Methods for detecting vasculopathies and tumors

Details Methods for detecting vasculopathies and tumors Methods for detecting vasculopathies and tumors

2006-07-04

2006-07-04

Wax, Robert A. (Department: 1653)

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

C435S006120, C530S350000, C530S387100

Reexamination Certificate

active

07070939

ABSTRACT:
This invention relates generally to the field of prognosis and diagnosis of vasculopathy and certain tumors. In particular, the invention provides a method for prognosing or diagnosing vasculopathy, neuroectodermal tumor, epithelial tumor, myelomonocytic tumor or lymphoid tumor in a mammal, which method comprises: a) assessing a NCAM L1 protein or a derivative or fragment thereof, or a mRNA encoding said NCAM L1 protein or a derivative or fragment thereof, in a mammal having or suspected of having vasculopathy, neuroectodermal tumor, epithelial tumor, lymphoid tumor or myelomonocytic tumor; b) assessing a NCAM L1 protein or a derivative or fragment thereof, or a mRNA encoding said NCAM L1 protein or a derivative or fragment thereof, in a mammal not having said vasculopathy, neuroectodermal tumor, epithelial tumor, lymphoid tumor or myelomonocytic tumor; c) comparing the presence or quantity of said NCAM L1 protein or mRNA assessed in steps a) and b), whereby said NCAM L1 protein or mRNA assessed in step a) is more than that assessed in step b) indicates the presence of said vasculopathy, neuroectodermal tumor, epithelial tumor, lymphoid tumor or myelomonocytic tumor in said mammal. The method can also be used for monitoring the effectiveness of the treatment of the vasculopathy, neuroectodermal tumor, epithelial tumor, lymphoid tumor or myelomonocytic tumor.

REFERENCES:
patent: 3464890 (1969-09-01), Weichselbaum
patent: 3647070 (1972-03-01), Adler
patent: 3780935 (1973-12-01), Lukacs et al.
patent: 3852194 (1974-12-01), Zine, Jr.
patent: 4140631 (1979-02-01), Okuda et al.
patent: 4477575 (1984-10-01), Vogel et al.
patent: 4803153 (1989-02-01), Shibata et al.
patent: 5364533 (1994-11-01), Ogura et al.
patent: 5969124 (1999-10-01), Lemmon
patent: 0572664 (1999-12-01), None
patent: WO 98/36062 (1998-08-01), None
patent: WO-02/04952 (2002-01-01), None
Ong et al., “Serum neural adhesion molecule differentiates multiple myeloma from paraproteinemias due to other causes,” Blood 87(2) :712-718, 1996.
Disease Information Fact Sheet 17, The chronic myelomonocytic leukemias (CMML), The Leukemia & Lymphoma Society, http://www.leukemia-lymphoma.org/all—mat—toc.adp?item—id=69974&cat—id=1215, downloaded on Nov. 9, 2004.
Aunoble et al. “Major Oncogenes and Tumor Suppressor Genes Involved in Epithelial Ovarian Cancer (Review)” Int. J. Oncol. 16(3): 567-576 (2000).
Bergers et al. “Extrinsic Regulators of Epithelial Tumor Progression: metalloproteinases” Curr. Opin. Genet. Dev. 10(1): 120-127 (2000).
Ching et al. “CT and MR Imaging Appearances of an Extraosseous Calcifying Epithelial Odontogenic Tumor (Pindborg Tumor)” Am. J. Neuroradiol. 21(2): 343-345 (2000).
De Alava et al. “Molecular Biology of the Ewing's Sarcoma/Primitive Neuroectodermal Tumor Family” J. Clin. Oncol. 18(1): 204-213 (2000).
De Souza et al. “Cell Cycle-Associated Proteins in Melanotic Neuroectodermal Tumor of Infancy”.
Ferrara et al. “CD56 Expression Is an Indicator of Poor Clinical Outcome in Patients with Acute Promyelocytic-Leukemia Treated with Simultaneous All-Trans-Retinoic Acid and Chemotherapy” J. Clin. Oncol. 18(6):1295-1300 (2000).
Hage et al. “Neural Cell Adhesion Molecule Expression” Chest 114: 1316-1320 (1998).
Jennette et al. “Small-Vessel Vasculititis” N. Engl. J. Med. 337(21):1512-1523 (1997).
Kaya et al. “Melanotic Neuroectodermal Tumor of Infancy Report of Two Cases and Review of Literature” Int. J. Pediatr. Otorhinolaryngol. 52(2):169-172 (2000).
Kiratli et al. “Primitive Neuroectodermal Tumor of the Orbit in an Adult” Ophthalmology 106(1): 98-102 (1999).
Komminoth et al. “Overlapping Expression of Immunohistochemical Markers and Synaptophysin mRNA in Pheochromocytomas and Adrenocortical Carcinomas” Laboratory Investigation 72(4):424-431 (1995).
Lieutaud et al. “Renal and Adrenal Gland Localization of Chronic Myelomonocytic Leukemia Presenting as a Kidney Tumor” Leuk. Lymphoma 34(3-4): 405-408 (1999).
Mat et al. “Small Vessel Vasculitis and Vasculitis Confined to Skin” Baillieres Clin. Rheumatol. 11(2): 237-257 (1997).
Moos et al. “Neural Adhesion Molecule L1 as a Member of the Immunoglobulin Superfamily with Binding Domains Similar to Fibronectin” Nature 334: 701-703 (1988).
Ong et al. “Serum Neural Cell Adhesion Molecule Differentiates Multiple Myeloma from Paraproteinemias Due to Other Causes” Blood 87(2):712-716 (1996).
Toda et al. “Primitive Neuroectodermal Tumor in Sinonasal Region” Auris Nasus Larynx 26(1): 83-90 (1999).
Watson et al.Molecular Biology of the Gene4thEd. The Bejacmin/Cummings Pub. Co. p. 224 (1987).
Allory et al., Clinical Cancer Research (2005) 11:1190-1197.
Calvo et al., Cancer Research (2002) 62:5325-5335.
Figarella-Branger et al., Cancer Research (1990) 50:6364-6370.
Fogel et al., The Lancet (2003) 362:869-875.
Gavert et al., The Journal of Cell Biology (2005) 168(4):633-642.
Katayama et al., Cell Structure and Function (1997) 22:511-516.
Meli et al., Int. J. Cancer (1999) 83:401-408.
Montgomery et al., The Journal of Cell Biology (1996) 132(3):475-485.
Mujoo et al., The Journal of Biological Chemistry (1986) 261(22):10299-10305.
Primiano et al., Cancer Cell (2003) 4:41-53.
Suzuki et al., J. Clin. Pathol. (2005) 58:166-171.
Thies et al., European Journal of Cancer (2002) 38:1708-1716.

Affiliated with

Also associated with

Rating

Methods for detecting vasculopathies and tumors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for detecting vasculopathies and tumors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for detecting vasculopathies and tumors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3569874